• 2007

Company Description

DiscGenics develops tissue engineering and progenitor cell science for the treatment of degenerative disc disease.

Discgenics, Inc. operates as a disc stem cell company which uses its tissue engineering platform technology as an alternative to current therapeutic modalities for the treatment of degenerative disc disease. The company was incorporated in 2007 and is based in Memphis, Tennessee.Now it is located at salt lake city,Utah.